BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37848355)

  • 1. Perioperative genetic testing and time to surgery in patients with breast cancer.
    Wu V; Chichura AM; Dickard J; Turner C; Al-Hilli Z
    Surgery; 2024 Mar; 175(3):712-717. PubMed ID: 37848355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
    Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
    Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
    Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
    JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.
    Al-Hilli Z; Noss R; Dickard J; Wei W; Chichura A; Wu V; Renicker K; Pederson HJ; Eng C
    Ann Surg Oncol; 2023 Oct; 30(10):5990-5996. PubMed ID: 37567976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
    Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
    Beitsch PD; Whitworth PW; Hughes K; Patel R; Rosen B; Compagnoni G; Baron P; Simmons R; Smith LA; Grady I; Kinney M; Coomer C; Barbosa K; Holmes DR; Brown E; Gold L; Clark P; Riley L; Lyons S; Ruiz A; Kahn S; MacDonald H; Curcio L; Hardwick MK; Yang S; Esplin ED; Nussbaum RL
    J Clin Oncol; 2019 Feb; 37(6):453-460. PubMed ID: 30526229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal Genetic Testing for All Breast Cancer Patients.
    Copur MS
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
    Childers CP; Childers KK; Maggard-Gibbons M; Macinko J
    J Clin Oncol; 2017 Dec; 35(34):3800-3806. PubMed ID: 28820644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of large panel genetic evaluation of breast cancer patients in a community-based cancer institute.
    Bagwell AK; Sutton TL; Gardiner S; Johnson N
    Am J Surg; 2021 Jun; 221(6):1159-1163. PubMed ID: 33849710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
    Dettwyler SA; Thull DL; McAuliffe PF; Steiman JG; Johnson RR; Diego EJ; Mai PL
    Breast Cancer Res Treat; 2022 Jul; 194(2):393-401. PubMed ID: 35596825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an embedded genetic counselor on breast cancer treatment.
    Pederson HJ; Hussain N; Noss R; Yanda C; O'Rourke C; Eng C; Grobmyer SR
    Breast Cancer Res Treat; 2018 May; 169(1):43-46. PubMed ID: 29349711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Surgeon in the Germline Testing of the Newly Diagnosed Breast Cancer Patient.
    Schick S; Manghelli J; Ludwig KK
    Curr Oncol; 2023 May; 30(5):4677-4687. PubMed ID: 37232811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
    Szender JB; Kaur J; Clayback K; Hutton ML; Mikkelson J; Odunsi K; Dresbold C
    Int J Gynecol Cancer; 2018 Jan; 28(1):26-33. PubMed ID: 28930807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?
    Metcalfe KA; Narod SA; Eisen A; Poll A; Zamani N; McCready D; Cil TD; Wright FC; Lerner-Ellis J; McCuaig J; Graham T; Sun P; Akbari MR
    Cancer Med; 2023 Mar; 12(6):7580-7587. PubMed ID: 36544278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
    Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
    Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice.
    Doherty J; Bonadies DC; Matloff ET
    J Genet Couns; 2015 Aug; 24(4):683-7. PubMed ID: 25475920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
    Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
    J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.